Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Breast Cancer

  Free Subscription


Articles published in Clin Breast Cancer

Retrieve available abstracts of 170 articles:
HTML format
Text format



Single Articles


    November 2018
  1. THORNELOE RJ, Horne R, Side L, Wolf MS, et al
    Beliefs About Medication and Uptake of Preventive Therapy in Women at Increased Risk of Breast Cancer: Results From a Multicenter Prospective Study.
    Clin Breast Cancer. 2018 Nov 22. pii: S1526-8209(18)30533.
    PubMed     Text format     Abstract available


  2. CHEN H, Zhang M, Wang M, Zhang P, et al
    Immediate Breast Reconstruction in De Novo Metastatic Breast Cancer: An Analysis of 563 Cases Based on the SEER Database.
    Clin Breast Cancer. 2018 Nov 5. pii: S1526-8209(18)30678.
    PubMed     Text format     Abstract available


  3. FARAROUEI M, Iqbal A, Rezaian S, Gheibi Z, et al
    Dietary Habits and Physical Activity are Associated With the Risk of Breast Cancer Among Young Iranian Women: A Case-control Study on 1010 Premenopausal Women.
    Clin Breast Cancer. 2018 Nov 2. pii: S1526-8209(18)30622.
    PubMed     Text format     Abstract available


  4. CHEN W, Zhang J, Huang L, Chen L, et al
    Detection of HER2-positive Circulating Tumor Cells Using the LiquidBiopsy System in Breast Cancer.
    Clin Breast Cancer. 2018 Nov 1. pii: S1526-8209(18)30500.
    PubMed     Text format     Abstract available


  5. WANG K, Zhu GQ, Shi Y, Li ZY, et al
    Long-Term Survival Differences Between T1-2 Invasive Lobular Breast Cancer and Corresponding Ductal Carcinoma After Breast-Conserving Surgery: A Propensity-Scored Matched Longitudinal Cohort Study.
    Clin Breast Cancer. 2018 Nov 1. pii: S1526-8209(18)30467.
    PubMed     Text format     Abstract available


    October 2018
  6. BREAUX A, Turner B, Wu X, Rai SN, et al
    Impact of 21-Gene Expression Assay on Staging Estrogen Receptor-Positive HER2-Negative Breast Cancer.
    Clin Breast Cancer. 2018 Oct 29. pii: S1526-8209(18)30561.
    PubMed     Text format     Abstract available


  7. BRANDINI DA SILVA FC, Jose da Silva J, Sarri AJ, Paiva CE, et al
    Comprehensive Validation Study of Quality-of-Life Questionnaire Using Objective Clinical Measures: Breast Cancer Treatment Outcome Scale (BCTOS), Brazilian Portuguese Version.
    Clin Breast Cancer. 2018 Oct 27. pii: S1526-8209(18)30512.
    PubMed     Text format     Abstract available


  8. PASSILDAS J, Collard O, Savoye AM, Dohou J, et al
    Impact of Chemotherapy-induced Menopause in Women of Childbearing Age With Non-metastatic Breast Cancer - Preliminary Results From the MENOCOR Study.
    Clin Breast Cancer. 2018 Oct 23. pii: S1526-8209(18)30373.
    PubMed     Text format     Abstract available


  9. HURRIA A, Soto-Perez-de-Celis E, Blanchard S, Burhenn P, et al
    A Phase II Trial of Older Adults With Metastatic Breast Cancer Receiving nab-Paclitaxel: Melding the Fields of Geriatrics and Oncology.
    Clin Breast Cancer. 2018 Oct 16. pii: S1526-8209(18)30328.
    PubMed     Text format     Abstract available


  10. DING S, Wu J, Lin C, Chen W, et al
    Predictors for Survival and Distribution of 21-Gene Recurrence Score in Patients With Pure Mucinous Breast Cancer: A SEER Population-Based Retrospective Analysis.
    Clin Breast Cancer. 2018 Oct 13. pii: S1526-8209(18)30393.
    PubMed     Text format     Abstract available


  11. KAUFMAN PA, Wildiers H, Freyer G, Kemeny M, et al
    Phase 1b Study of Trebananib Plus Paclitaxel and Trastuzumab in Patients With HER2-Positive Locally Recurrent or Metastatic Breast Cancer.
    Clin Breast Cancer. 2018 Oct 9. pii: S1526-8209(18)30451.
    PubMed     Text format     Abstract available


  12. PANDEY A, Brufsky AM
    Metastatic Breast Cancer Patient With Activating HER2 Exon 20 Insertion Mutation With Response to Poziotinib: Case Report of Compassionate Drug Use.
    Clin Breast Cancer. 2018 Oct 4. pii: S1526-8209(18)30317.
    PubMed     Text format    


  13. XIAO YL, Wang K, Liu Q, Li J, et al
    Risk Reduction and Survival Benefit of Risk-Reducing Salpingo-oophorectomy in Hereditary Breast Cancer: Meta-analysis and Systematic Review.
    Clin Breast Cancer. 2018 Oct 4. pii: S1526-8209(18)30521.
    PubMed     Text format     Abstract available


  14. KAPILA AK, Hamdi M, Patel A
    Clinicians Should Actively Promote Exercise in Survivors of Breast Cancer.
    Clin Breast Cancer. 2018;18:e747-e749.
    PubMed     Text format     Abstract available


  15. GINZAC A, Thivat E, Mouret-Reynier MA, Dubray-Longeras P, et al
    Weight Evolution During Endocrine Therapy for Breast Cancer in Postmenopausal Patients: Effect of Initial Fat Mass Percentage and Previous Adjuvant Treatments.
    Clin Breast Cancer. 2018;18:e1093-e1102.
    PubMed     Text format     Abstract available


    September 2018
  16. PAN H, Zhang K, Wang M, Ling L, et al
    Palliative Local Surgery for Locally Advanced Breast Cancer Depending on Hormone Receptor Status in Elderly Patients.
    Clin Breast Cancer. 2018 Sep 27. pii: S1526-8209(18)30510.
    PubMed     Text format     Abstract available


  17. NAKAGAWA M, Ikeuchi M, Morimoto M, Takechi H, et al
    Phase II Study of S-1 Combined With Low-Dose Docetaxel as Neoadjuvant Chemotherapy for Operable Breast Cancer Patients (N-1 Study).
    Clin Breast Cancer. 2018 Sep 27. pii: S1526-8209(18)30262.
    PubMed     Text format     Abstract available


  18. KOWALCZYK R, Nowosielski K, Cedrych I, Krzystanek M, et al
    Factors Affecting Sexual Function and Body Image of Early-Stage Breast Cancer Survivors in Poland: A Short-Term Observation.
    Clin Breast Cancer. 2018 Sep 21. pii: S1526-8209(18)30474.
    PubMed     Text format     Abstract available


  19. BAWAZIR A, Bashateh N, Jradi H, Breik AB, et al
    Breast Cancer Screening Awareness and Practices Among Women Attending Primary Health Care Centers in the Ghail Bawazir District of Yemen.
    Clin Breast Cancer. 2018 Sep 20. pii: S1526-8209(18)30429.
    PubMed     Text format     Abstract available


  20. SHAKER OG, Senousy MA
    Association of SNP-SNP Interactions Between RANKL, OPG, CHI3L1, and VDR Genes With Breast Cancer Risk in Egyptian Women.
    Clin Breast Cancer. 2018 Sep 19. pii: S1526-8209(18)30444.
    PubMed     Text format     Abstract available


  21. WATSON GA, Deac O, Aslam R, O'Dwyer R, et al
    Real-World Experience of Palbociclib-Induced Adverse Events and Compliance With Complete Blood Count Monitoring in Women With Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer.
    Clin Breast Cancer. 2018 Sep 8. pii: S1526-8209(18)30507.
    PubMed     Text format     Abstract available


  22. HSU W, Zhou X, Petruse A, Chau N, et al
    Role of Clinical and Imaging Risk Factors in Predicting Breast Cancer Diagnosis Among BI-RADS 4 Cases.
    Clin Breast Cancer. 2018 Sep 5. pii: S1526-8209(18)30258.
    PubMed     Text format     Abstract available


  23. MCGEE SF, Vandermeer L, Mazzarello S, Sienkiewicz M, et al
    Physician Survey of Timing of Adjuvant Endocrine Therapy Relative to Radiotherapy in Early Stage Breast Cancer Patients.
    Clin Breast Cancer. 2018 Sep 4. pii: S1526-8209(18)30204.
    PubMed     Text format     Abstract available


    August 2018
  24. BERHILI S, Ouabdelmoumen A, Sbai A, Kebdani T, et al
    Radical Mastectomy Increases Psychological Distress in Young Breast Cancer Patients: Results of A Cross-sectional Study.
    Clin Breast Cancer. 2018 Aug 31. pii: S1526-8209(18)30522.
    PubMed     Text format     Abstract available


  25. XIE J, Yang Y, Sun J, Jiao Z, et al
    STEAP1 Inhibits Breast Cancer Metastasis and Is Associated With Epithelial-Mesenchymal Transition Procession.
    Clin Breast Cancer. 2018 Aug 30. pii: S1526-8209(18)30378.
    PubMed     Text format     Abstract available


  26. HAYASHI N, Tsunoda H, Namura M, Ochi T, et al
    Magnetic Resonance Imaging Combined With Second-look Ultrasonography in Predicting Pathologic Complete Response After Neoadjuvant Chemotherapy in Primary Breast Cancer Patients.
    Clin Breast Cancer. 2018 Aug 24. pii: S1526-8209(18)30234.
    PubMed     Text format     Abstract available


  27. YARDLEY DA, Shipley D, Zubkus J, Wright GL, et al
    A Randomized Phase II Study of Eribulin/Cyclophosphamide or Docetaxel/Cyclophosphamide as Neoadjuvant Therapy in Operable HER2-negative Breast Cancer.
    Clin Breast Cancer. 2018 Aug 23. pii: S1526-8209(18)30132.
    PubMed     Text format     Abstract available


  28. PISTILLI B, Mazouni C, Zingarello A, Faron M, et al
    Individualized Prediction of Menses Recovery After Chemotherapy for Early-stage Breast Cancer: A Nomogram Developed From UNICANCER PACS04 and PACS05 Trials.
    Clin Breast Cancer. 2018 Aug 23. pii: S1526-8209(18)30264.
    PubMed     Text format     Abstract available


  29. HAMMER J, Geinitz H, Nieder C, Track C, et al
    Risk Factors for Local Relapse and Inferior Disease-free Survival After Breast-conserving Management of Breast Cancer: Recursive Partitioning Analysis of 2161 Patients.
    Clin Breast Cancer. 2018 Aug 22. pii: S1526-8209(18)30241.
    PubMed     Text format     Abstract available


  30. ALARCON ROJAS CA, Alvarez-Banuelos MT, Morales-Romero J, Suarez-Diaz H, et al
    Breast Cancer: Metastasis, Molecular Subtypes, and Overweight and Obesity in Veracruz, Mexico.
    Clin Breast Cancer. 2018 Aug 22. pii: S1526-8209(18)30366.
    PubMed     Text format     Abstract available


  31. THRIVENI K, Raju A, Kumar RV, Krishnamurthy S, et al
    Patterns of Relative Telomere Length is Associated With hTERT Gene Expression in the Tissue of Patients With Breast Cancer.
    Clin Breast Cancer. 2018 Aug 22. pii: S1526-8209(18)30372.
    PubMed     Text format     Abstract available


  32. YAN M, Abdi MA, Falkson C
    Axillary Management in Breast Cancer Patients: A Comprehensive Review of the Key Trials.
    Clin Breast Cancer. 2018 Aug 22. pii: S1526-8209(18)30448.
    PubMed     Text format     Abstract available


  33. GUILLEMOIS S, Patsouris A, Peyraga G, Chassain K, et al
    Cutaneous and Gastrointestinal Leukocytoclastic Vasculitis Induced by Palbociclib in a Metastatic Breast Cancer Patient: A Case Report.
    Clin Breast Cancer. 2018 Aug 14. pii: S1526-8209(18)30313.
    PubMed     Text format    


  34. MARSCHNER N, Salat C, Soling U, Hansen R, et al
    Final Effectiveness and Safety Results of NABUCCO: Real-World Data From a Noninterventional, Prospective, Multicenter Study in 697 Patients With Metastatic Breast Cancer Treated With nab-Paclitaxel.
    Clin Breast Cancer. 2018 Aug 9. pii: S1526-8209(18)30064.
    PubMed     Text format     Abstract available


  35. RUGO HS, Roche H, Thomas E, Chung HC, et al
    Efficacy and Safety of Ixabepilone and Capecitabine in Patients With Advanced Triple-negative Breast Cancer: a Pooled Analysis From Two Large Phase III, Randomized Clinical Trials.
    Clin Breast Cancer. 2018 Aug 4. pii: S1526-8209(18)30266.
    PubMed     Text format     Abstract available


  36. SPORIKOVA Z, Koudelakova V, Trojanec R, Hajduch M, et al
    Genetic Markers in Triple-Negative Breast Cancer.
    Clin Breast Cancer. 2018 Aug 4. pii: S1526-8209(18)30093.
    PubMed     Text format     Abstract available


  37. HE J, Gu Y, Zhang S
    Vitamin A and Breast Cancer Survival: A Systematic Review and Meta-analysis.
    Clin Breast Cancer. 2018 Aug 4. pii: S1526-8209(18)30305.
    PubMed     Text format     Abstract available


  38. JI G, Zhang C, Guan S, Yao X, et al
    Erlotinib for Progressive Brain and Leptomeningeal Metastases From HER2-positive Breast Cancer After Treatment Failure With Trastuzumab and Lapatinib: Experience and Review of Literature.
    Clin Breast Cancer. 2018 Aug 4. pii: S1526-8209(18)30384.
    PubMed     Text format    


    July 2018
  39. STEARNS V, Brufsky AM, Verma S, Cotter MJ, et al
    Expanded-Access Study of Palbociclib in Combination With Letrozole for Treatment of Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer.
    Clin Breast Cancer. 2018 Jul 30. pii: S1526-8209(18)30306.
    PubMed     Text format     Abstract available


  40. RAPHAEL J, Kiss A, Nofech-Mozes S, Trudeau M, et al
    Clinical Outcomes of Single Versus Double Hormone Receptor-Positive Breast Cancer Patients Treated With Neoadjuvant Chemotherapy.
    Clin Breast Cancer. 2018 Jul 29. pii: S1526-8209(18)30118.
    PubMed     Text format     Abstract available


  41. ALI OS, Shabayek MI, Seleem MM, Abdellateif HG, et al
    MicroRNAs 182 and 375 Sera Expression as Prognostic Biochemical Markers in Breast Cancer.
    Clin Breast Cancer. 2018 Jul 29. pii: S1526-8209(18)30232.
    PubMed     Text format     Abstract available


  42. ABDEL-RAHMAN O
    Impact of Regional Nodal Irradiation on the Outcomes of N1 Breast Cancer Patients Referred for Adjuvant Treatment: A Patient-Level Pooled Analysis of 2 Clinical Trials.
    Clin Breast Cancer. 2018 Jul 24. pii: S1526-8209(18)30085.
    PubMed     Text format     Abstract available


  43. CHEN X, Fan Y, Xu B
    Distinct Characteristics and Metastatic Behaviors of Late Recurrence in Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor 2-negative Breast Cancer: A Single Institute Experience of More Than 10 Years.
    Clin Breast Cancer. 2018 Jul 24. pii: S1526-8209(18)30303.
    PubMed     Text format     Abstract available


  44. KURUNDKAR A, Gao X, Zhang K, Britt JP, et al
    Comparison of AJCC Anatomic and Clinical Prognostic Stage Groups in Breast Cancer: Analysis of 3322 Cases From a Single Institution.
    Clin Breast Cancer. 2018 Jul 17. pii: S1526-8209(18)30230.
    PubMed     Text format     Abstract available


  45. BUECHLER SA, Gokmen-Polar Y, Badve SS
    EarlyR: A Robust Gene Expression Signature for Predicting Outcomes of Estrogen Receptor-Positive Breast Cancer.
    Clin Breast Cancer. 2018 Jul 17. pii: S1526-8209(18)30012.
    PubMed     Text format     Abstract available


  46. MURTHY RK, Raghavendra AS, Hess KR, Fujii T, et al
    Neoadjuvant Pertuzumab-containing Regimens Improve Pathologic Complete Response Rates in Stage II to III HER-2/neu-positive Breast Cancer: A Retrospective, Single Institution Experience.
    Clin Breast Cancer. 2018 Jul 10. pii: S1526-8209(18)30009.
    PubMed     Text format     Abstract available


  47. LELIEVRE L, Clezardin P, Magaud L, Roche L, et al
    Comparative Study of Neoadjuvant Chemotherapy With and Without Zometa for Management of Locally Advanced Breast Cancer With Serum VEGF as Primary Endpoint: The NEOZOL Study.
    Clin Breast Cancer. 2018 Jul 10. pii: S1526-8209(18)30121.
    PubMed     Text format     Abstract available


  48. ABD-ELHAY FA, Elhusseiny KM, Kamel MG, Low SK, et al
    Negative Lymph Node Count and Lymph Node Ratio Are Associated With Survival in Male Breast Cancer.
    Clin Breast Cancer. 2018 Jul 7. pii: S1526-8209(18)30061.
    PubMed     Text format     Abstract available


  49. BAXTER DE, Kim B, Hanby AM, Verghese ET, et al
    Neoadjuvant Endocrine Therapy in Breast Cancer Upregulates the Cytotoxic Drug Pump ABCG2/BCRP, and May Lead to Resistance to Subsequent Chemotherapy.
    Clin Breast Cancer. 2018 Jul 6. pii: S1526-8209(18)30447.
    PubMed     Text format     Abstract available


  50. YEE C, Wang K, Asthana R, Drost L, et al
    Radiation-induced Skin Toxicity in Breast Cancer Patients: A Systematic Review of Randomized Trials.
    Clin Breast Cancer. 2018 Jul 4. pii: S1526-8209(18)30114.
    PubMed     Text format     Abstract available


    June 2018
  51. LIU N, Johnson KJ, Ma CX
    Male Breast Cancer: An Updated Surveillance, Epidemiology, and End Results Data Analysis.
    Clin Breast Cancer. 2018 Jun 27. pii: S1526-8209(18)30016.
    PubMed     Text format     Abstract available


  52. WANG J, Wang S, Tang Y, Jing H, et al
    Comparison of Treatment Outcomes With Breast-conserving Surgery Plus Radiotherapy Versus Mastectomy for Patients With Stage I Breast Cancer: A Propensity Score-matched Analysis.
    Clin Breast Cancer. 2018 Jun 27. pii: S1526-8209(18)30115.
    PubMed     Text format     Abstract available


  53. KUWAYAMA T, Nakamura S, Hayashi N, Takano T, et al
    Randomized Multicenter Phase II Trial of Neoadjuvant Therapy Comparing Weekly Nab-paclitaxel Followed by FEC With Docetaxel Followed by FEC in HER2(-) Early-stage Breast Cancer.
    Clin Breast Cancer. 2018 Jun 27. pii: S1526-8209(16)30572.
    PubMed     Text format     Abstract available


  54. NASEHI L, Sturgis CD, Sharma N, Turk P, et al
    Breast Cancer Risk Associated With Benign Intraductal Papillomas Initially Diagnosed on Core Needle Biopsy.
    Clin Breast Cancer. 2018 Jun 21. pii: S1526-8209(18)30228.
    PubMed     Text format     Abstract available


  55. SHEEHY EM, Lehane E, Quinn E, Livingstone V, et al
    Information Needs of Patients With Breast Cancer at Years One, Three, and Five After Diagnosis.
    Clin Breast Cancer. 2018 Jun 18. pii: S1526-8209(18)30130.
    PubMed     Text format     Abstract available


  56. CHEN J, Wu X, Christos P, Yan W, et al
    Adjuvant Radiation Therapy for T3N0 Breast Cancer Patients Older Than 75 Years After Mastectomy: A SEER Analysis.
    Clin Breast Cancer. 2018 Jun 15. pii: S1526-8209(17)30641.
    PubMed     Text format     Abstract available


  57. ZHU X, Huang JM, Zhang K, Xia LJ, et al
    Diagnostic Value of Contrast-Enhanced Spectral Mammography for Screening Breast Cancer: Systematic Review and Meta-analysis.
    Clin Breast Cancer. 2018 Jun 15. pii: S1526-8209(18)30008.
    PubMed     Text format     Abstract available


  58. KIM Y, Sim SH, Park B, Lee KS, et al
    Magnetic Resonance Imaging (MRI) Assessment of Residual Breast Cancer After Neoadjuvant Chemotherapy: Relevance to Tumor Subtypes and MRI Interpretation Threshold.
    Clin Breast Cancer. 2018 Jun 7. pii: S1526-8209(18)30300.
    PubMed     Text format     Abstract available


  59. MORI H, Kubo M, Kai M, Velasquez VV, et al
    BRCAness Combined With a Family History of Cancer Is Associated With a Poor Prognosis for Breast Cancer Patients With a High Risk of BRCA Mutations.
    Clin Breast Cancer. 2018 Jun 2. pii: S1526-8209(18)30022.
    PubMed     Text format     Abstract available


    May 2018
  60. SIOTOS C, McColl M, Psoter K, Gilmore RC, et al
    Tumor Site and Breast Cancer Prognosis.
    Clin Breast Cancer. 2018 May 29. pii: S1526-8209(18)30299.
    PubMed     Text format     Abstract available


  61. KIM HJ, Kang E, Kim JH, Kim SH, et al
    Survival Benefit of Surgical Removal of Primary Tumor in Patients With Stage IV Breast Cancer.
    Clin Breast Cancer. 2018 May 28. pii: S1526-8209(18)30104.
    PubMed     Text format     Abstract available


  62. CHEN M, Pockaj B, Andreozzi M, Barrett MT, et al
    JAK2 and PD-L1 Amplification Enhance the Dynamic Expression of PD-L1 in Triple-negative Breast Cancer.
    Clin Breast Cancer. 2018 May 26. pii: S1526-8209(17)30780.
    PubMed     Text format     Abstract available


  63. LECLERC AF, Slomian J, Jerusalem G, Coucke P, et al
    Exercise and Education Program After Breast Cancer: Benefits on Quality of Life and Symptoms at 3, 6, 12, and 24 Months' Follow-up.
    Clin Breast Cancer. 2018 May 19. pii: S1526-8209(17)30809.
    PubMed     Text format     Abstract available


  64. CO M, Ng J, Kwong A
    Air Travel Safety in Postoperative Breast Cancer Patients: A Systematic Review.
    Clin Breast Cancer. 2018 May 17. pii: S1526-8209(18)30236.
    PubMed     Text format     Abstract available


  65. KOZAK MM, Jacobson CE, von Eyben R, Walck E, et al
    Patterns of Distant Failure by Intrinsic Breast Cancer Subtype in Premenopausal Women Treated With Neoadjuvant Chemotherapy.
    Clin Breast Cancer. 2018 May 7. pii: S1526-8209(17)30796.
    PubMed     Text format     Abstract available


  66. MCINTIRE PJ, Irshaid L, Liu Y, Chen Z, et al
    Hot Spot and Whole-Tumor Enumeration of CD8(+) Tumor-Infiltrating Lymphocytes Utilizing Digital Image Analysis Is Prognostic in Triple-Negative Breast Cancer.
    Clin Breast Cancer. 2018 May 7. pii: S1526-8209(17)30839.
    PubMed     Text format     Abstract available


  67. DENG Y, Ma G, Li W, Wang T, et al
    CDK4/6 Inhibitors in Combination With Hormone Therapy for HR(+)/HER2(-) Advanced Breast Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Clin Breast Cancer. 2018 May 4. pii: S1526-8209(17)30798.
    PubMed     Text format     Abstract available


  68. JABIR RS, Ho GF, Annuar MABA, Stanslas J, et al
    Association of Allelic Interaction of Single Nucleotide Polymorphisms of Influx and Efflux Transporters Genes With Nonhematologic Adverse Events of Docetaxel in Breast Cancer Patients.
    Clin Breast Cancer. 2018 May 4. pii: S1526-8209(17)30628.
    PubMed     Text format     Abstract available


    April 2018
  69. LADWA R, Kalas T, Pathmanathan S, Woodward N, et al
    Maintaining Dose Intensity of Adjuvant Chemotherapy in Older Patients With Breast Cancer.
    Clin Breast Cancer. 2018 Apr 28. pii: S1526-8209(18)30105.
    PubMed     Text format     Abstract available


  70. DHAKAL A, Matthews CM, Levine EG, Salerno KE, et al
    Efficacy of Palbociclib Combinations in Hormone Receptor-Positive Metastatic Breast Cancer Patients After Prior Everolimus Treatment.
    Clin Breast Cancer. 2018 Apr 28. pii: S1526-8209(17)30805.
    PubMed     Text format     Abstract available


  71. KOPS NL, Bessel M, Caleffi M, Ribeiro RA, et al
    Body Weight and Breast Cancer: Nested Case-Control Study in Southern Brazil.
    Clin Breast Cancer. 2018 Apr 28. pii: S1526-8209(18)30073.
    PubMed     Text format     Abstract available


  72. RAYSON D, Payne JI, Michael JCR, Tsuruda KM, et al
    Impact of Detection Method and Age on Survival Outcomes in Triple-Negative Breast Cancer: A Population-Based Cohort Analysis.
    Clin Breast Cancer. 2018 Apr 28. pii: S1526-8209(17)30829.
    PubMed     Text format     Abstract available


  73. CHO WK, Choi DH, Park W, Cha H, et al
    Effect of Body Mass Index on Survival in Breast Cancer Patients According to Subtype, Metabolic Syndrome, and Treatment.
    Clin Breast Cancer. 2018 Apr 19. pii: S1526-8209(17)30765.
    PubMed     Text format     Abstract available


  74. QINGQING H, Jian Z, Dayong Z, Ziyi F, et al
    Robot-Assisted Internal Mammary Lymph Node Chain Dissection for Breast Cancer.
    Clin Breast Cancer. 2018 Apr 19. pii: S1526-8209(18)30134.
    PubMed     Text format    


  75. KIM HJ, Lee MH, Lee JE, Park S, et al
    Oncologic Safety of Gonadotropin-Releasing Hormone Agonist for Ovarian Function Protection During Breast Cancer Chemotherapy.
    Clin Breast Cancer. 2018 Apr 19. pii: S1526-8209(18)30019.
    PubMed     Text format     Abstract available


  76. HU ZY, Xiao H, Xiao M, Tang Y, et al
    Inducing or Preventing Subsequent Malignancies for Breast Cancer Survivors? Double-edged Sword of Estrogen Receptor and Progesterone Receptor.
    Clin Breast Cancer. 2018 Apr 19. pii: S1526-8209(18)30048.
    PubMed     Text format     Abstract available


  77. KENDZIERSKI DC, Schneider BP, Kiel PJ
    Efficacy of Different Leuprolide Administration Schedules in Premenopausal Breast Cancer: A Retrospective Review.
    Clin Breast Cancer. 2018 Apr 18. pii: S1526-8209(17)30722.
    PubMed     Text format     Abstract available


  78. CADOO KA, Kaufman PA, Seidman AD, Chang C, et al
    Phase 2 Study of Dose-Dense Doxorubicin and Cyclophosphamide Followed by Eribulin Mesylate With or Without Prophylactic Growth Factor for Adjuvant Treatment of Early-Stage Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer.
    Clin Breast Cancer. 2018 Apr 7. pii: S1526-8209(17)30768.
    PubMed     Text format     Abstract available


  79. NG T, Phey XY, Yeo HL, Shwe M, et al
    Impact of Adjuvant Anthracycline-Based and Taxane-Based Chemotherapy on Plasma VEGF Levels and Cognitive Function in Breast Cancer Patients: A Longitudinal Study.
    Clin Breast Cancer. 2018 Apr 6. pii: S1526-8209(17)30767.
    PubMed     Text format     Abstract available


  80. MUTSCHLER NS, Scholz C, Friedl TWP, Zwingers T, et al
    Prognostic Impact of Weight Change During Adjuvant Chemotherapy in Patients With High-Risk Early Breast Cancer: Results From the ADEBAR Study.
    Clin Breast Cancer. 2018;18:175-183.
    PubMed     Text format     Abstract available


    March 2018
  81. CORTES J, Perez-Garcia J, Whiting S, Wan Y, et al
    Quality-Adjusted Survival With nab-Paclitaxel Versus Standard Paclitaxel in Metastatic Breast Cancer: A Q-TWiST Analysis.
    Clin Breast Cancer. 2018 Mar 30. pii: S1526-8209(17)30778.
    PubMed     Text format     Abstract available


  82. KIM S, Moon BI, Lim W, Park S, et al
    Feasibility of Classification of Triple Negative Breast Cancer by Immunohistochemical Surrogate Markers.
    Clin Breast Cancer. 2018 Mar 23. pii: S1526-8209(17)30736.
    PubMed     Text format     Abstract available


  83. TAHERIPANAH R, Balash F, Anbiaee R, Mahmoodi M, et al
    Breast Cancer and Ovulation Induction Treatments.
    Clin Breast Cancer. 2018 Mar 15. pii: S1526-8209(17)30455.
    PubMed     Text format     Abstract available


  84. MORRIS PG, Rota S, Cadoo K, Zamora S, et al
    Phase II Study of Paclitaxel and Dasatinib in Metastatic Breast Cancer.
    Clin Breast Cancer. 2018 Mar 15. pii: S1526-8209(17)30810.
    PubMed     Text format     Abstract available


  85. UM E, Kang JW, Lee S, Kim HJ, et al
    Comparing Accuracy of Mammography and Magnetic Resonance Imaging for Residual Calcified Lesions in Breast Cancer Patients Undergoing Neoadjuvant Systemic Therapy.
    Clin Breast Cancer. 2018 Mar 15. pii: S1526-8209(17)30614.
    PubMed     Text format     Abstract available


  86. MATTHIESSEN LW, Keshtgar M, Curatolo P, Kunte C, et al
    Electrochemotherapy for Breast Cancer-Results From the INSPECT Database.
    Clin Breast Cancer. 2018 Mar 14. pii: S1526-8209(17)30397.
    PubMed     Text format     Abstract available


  87. REINERT T, Nogueira-Rodrigues A, Kestelman FP, Ashton-Prolla P, et al
    The Challenge of Evaluating Adnexal Masses in Patients With Breast Cancer.
    Clin Breast Cancer. 2018 Mar 12. pii: S1526-8209(18)30026.
    PubMed     Text format     Abstract available


  88. MIYAGAWA Y, Araki K, Bun A, Ozawa H, et al
    Significant Association Between Low Baseline Neutrophil-to-Lymphocyte Ratio and Improved Progression-free Survival of Patients With Locally Advanced or Metastatic Breast Cancer Treated With Eribulin But Not With Nab-Paclitaxel.
    Clin Breast Cancer. 2018 Mar 8. pii: S1526-8209(17)30724.
    PubMed     Text format     Abstract available


  89. COSPHIADI I, Atmakusumah TD, Siregar NC, Muthalib A, et al
    Bone Metastasis in Advanced Breast Cancer: Analysis of Gene Expression Microarray.
    Clin Breast Cancer. 2018 Mar 8. pii: S1526-8209(17)30777.
    PubMed     Text format     Abstract available


  90. YARDLEY DA, Hart LL, Ward PJ, Wright GL, et al
    Cabazitaxel Plus Lapatinib as Therapy for HER2(+) Metastatic Breast Cancer With Intracranial Metastases: Results of a Dose-finding Study.
    Clin Breast Cancer. 2018 Mar 8. pii: S1526-8209(17)30668.
    PubMed     Text format     Abstract available


  91. MEATTINI I, Pezzulla D, Saieva C, Bernini M, et al
    Triple Negative Apocrine Carcinomas as a Distinct Subtype of Triple Negative Breast Cancer: A Case-control Study.
    Clin Breast Cancer. 2018 Mar 2. pii: S1526-8209(18)30015.
    PubMed     Text format     Abstract available


    February 2018
  92. BINKLEY JM, Stratford P, Kirkpatrick S, Farley CR, et al
    Estimating the Reliability and Validity of the Upper Extremity Functional Index in Women After Breast Cancer Surgery.
    Clin Breast Cancer. 2018 Feb 21. pii: S1526-8209(18)30054.
    PubMed     Text format     Abstract available


  93. DEFAZIO MV, Dervishaj OA, Bozzuto LM, Pittman TA, et al
    Delayed Recurrent and Bilateral Breast Cancer in Patients With Partial Poland's Anomaly: Report of 2 Rare Cases and Review of the Literature.
    Clin Breast Cancer. 2018 Feb 20. pii: S1526-8209(17)30842.
    PubMed     Text format    


  94. HERSKOVIC AC, Wu X, Christos PJ, Nagar H, et al
    Omission of Adjuvant Radiotherapy in the Elderly Breast Cancer Patient: Missed Opportunity?
    Clin Breast Cancer. 2018 Feb 20. pii: S1526-8209(17)30782.
    PubMed     Text format     Abstract available


  95. RAO N, Chen K, Yang Q, Niu J, et al
    Proof-of-Concept Study of 3-D-Printed Mold-Guided Breast-Conserving Surgery in Breast Cancer Patients.
    Clin Breast Cancer. 2018 Feb 20. pii: S1526-8209(18)30039.
    PubMed     Text format     Abstract available


  96. YAMASHITA N, Tokunaga E, Iimori M, Inoue Y, et al
    Epithelial Paradox: Clinical Significance of Coexpression of E-cadherin and Vimentin With Regard to Invasion and Metastasis of Breast Cancer.
    Clin Breast Cancer. 2018 Feb 16. pii: S1526-8209(17)30629.
    PubMed     Text format     Abstract available


  97. ZAHEDI H, Djalalinia S, Sadeghi O, Asayesh H, et al
    Dietary Inflammatory Potential Score and Risk of Breast Cancer: Systematic Review and Meta-analysis.
    Clin Breast Cancer. 2018 Feb 7. pii: S1526-8209(17)30725.
    PubMed     Text format     Abstract available


  98. PALAZZO A, Dellapasqua S, Munzone E, Bagnardi V, et al
    Phase II Trial of Bevacizumab Plus Weekly Paclitaxel, Carboplatin, and Metronomic Cyclophosphamide With or Without Trastuzumab and Endocrine Therapy as Preoperative Treatment of Inflammatory Breast Cancer.
    Clin Breast Cancer. 2018 Feb 2. pii: S1526-8209(17)30737.
    PubMed     Text format     Abstract available


  99. CUI Q, Kong D, Li Z, Ahiable P, et al
    Dachshund 1 is Differentially Expressed Between Male and Female Breast Cancer: A Matched Case-Control Study of Clinical Characteristics and Prognosis.
    Clin Breast Cancer. 2018 Feb 2. pii: S1526-8209(17)30662.
    PubMed     Text format     Abstract available


  100. BLACKWELL K, Gligorov J, Jacobs I, Twelves C, et al
    The Global Need for a Trastuzumab Biosimilar for Patients With HER2-Positive Breast Cancer.
    Clin Breast Cancer. 2018 Feb 2. pii: S1526-8209(17)30406.
    PubMed     Text format     Abstract available


    January 2018
  101. HASHEMI M, Sanaei S, Hashemi SM, Eskandari E, et al
    Association of Single Nucleotide Polymorphisms of the MDM4 Gene With the Susceptibility to Breast Cancer in a Southeast Iranian Population Sample.
    Clin Breast Cancer. 2018 Jan 31. pii: S1526-8209(17)30804.
    PubMed     Text format     Abstract available


  102. ERSOY YE, Kadioglu H
    Review of Novel Sentinel Lymph Node Biopsy Techniques in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy.
    Clin Breast Cancer. 2018 Jan 31. pii: S1526-8209(17)30830.
    PubMed     Text format     Abstract available


  103. JABIR FA, Hoidy WH
    Pharmacogenetics as Personalized Medicine: Association Investigation of SOD2 rs4880, CYP2C19 rs4244285, and FCGR2A rs1801274 Polymorphisms in a Breast Cancer Population in Iraqi Women.
    Clin Breast Cancer. 2018 Jan 31. pii: S1526-8209(17)30534.
    PubMed     Text format     Abstract available


  104. FARD ZT, Nafisi N
    The Relationship Between 6 Polymorphisms of Caveolin-1 Gene and the Risk of Breast Cancer.
    Clin Breast Cancer. 2018 Jan 31. pii: S1526-8209(16)30439.
    PubMed     Text format     Abstract available


  105. KOJIMA Y, Kawamoto H, Nishikawa T, Hayami R, et al
    Feasibility Study of Weekly Nanoparticle Albumin-Bound Paclitaxel (150 mg/m(2)) Followed by Fluorouracil, Epirubicin, and Cyclophosphamide Therapy as Neoadjuvant Chemotherapy for HER2-Negative Breast Cancer.
    Clin Breast Cancer. 2018 Jan 11. pii: S1526-8209(17)30615.
    PubMed     Text format     Abstract available


  106. GU J, Groot G, Boden C, Busch A, et al
    Review of Factors Influencing Women's Choice of Mastectomy Versus Breast Conserving Therapy in Early Stage Breast Cancer: A Systematic Review.
    Clin Breast Cancer. 2018 Jan 3. pii: S1526-8209(17)30691.
    PubMed     Text format     Abstract available


    December 2017
  107. YADAV S, Ladkany R, Yadav D, Alhalabi O, et al
    Impact of BRCA Mutation Status on Survival of Women With Triple-negative Breast Cancer.
    Clin Breast Cancer. 2017 Dec 30. pii: S1526-8209(17)30334.
    PubMed     Text format     Abstract available


  108. WU JD, Hong CQ, Huang WH, Wei XL, et al
    L1 Cell Adhesion Molecule and Its Soluble Form sL1 Exhibit Poor Prognosis in Primary Breast Cancer Patients.
    Clin Breast Cancer. 2017 Dec 28. pii: S1526-8209(17)30523.
    PubMed     Text format     Abstract available


  109. BHAVE MA, Speth KA, Kidwell KM, Lyden A, et al
    Effect of Aromatase Inhibitor Therapy on Sleep and Activity Patterns in Early-stage Breast Cancer.
    Clin Breast Cancer. 2017 Dec 27. pii: S1526-8209(17)30624.
    PubMed     Text format     Abstract available


  110. MORIKAWA A, Wang R, Patil S, Diab A, et al
    Characteristics and Prognostic Factors for Patients With HER2-overexpressing Breast Cancer and Brain Metastases in the Era of HER2-targeted Therapy: An Argument for Earlier Detection.
    Clin Breast Cancer. 2017 Dec 21. pii: S1526-8209(17)30394.
    PubMed     Text format     Abstract available


  111. GORNSTEIN EL, Sandefur S, Chung JH, Gay LM, et al
    BRCA2 Reversion Mutation Associated With Acquired Resistance to Olaparib in Estrogen Receptor-positive Breast Cancer Detected by Genomic Profiling of Tissue and Liquid Biopsy.
    Clin Breast Cancer. 2017 Dec 21. pii: S1526-8209(17)30680.
    PubMed     Text format    


  112. YERUVA SLH, Javadi MS, Stearns V
    Complete Response to Single-agent Palbociclib in Metastatic Breast Cancer: A Case Report.
    Clin Breast Cancer. 2017 Dec 21. pii: S1526-8209(17)30533.
    PubMed     Text format    


  113. MEISEL J, Zhang C, Neely C, Mendoza P, et al
    Evaluation of Prognosis in Hormone Receptor-Positive/HER2-Negative and Lymph Node-Negative Breast Cancer With Low Oncotype DX Recurrence Score.
    Clin Breast Cancer. 2017 Dec 14. pii: S1526-8209(17)30562.
    PubMed     Text format     Abstract available


  114. MOLDERINGS GJ, Knuchel-Clarke R, Hertfelder HJ, Kuhl C, et al
    Mast Cell Activation Syndrome Mimicking Breast Cancer: Case Report With Pathophysiologic Considerations.
    Clin Breast Cancer. 2017 Dec 12. pii: S1526-8209(17)30532.
    PubMed     Text format    


  115. KUBA S, Maeda S, Matsumoto M, Yamanouchi K, et al
    Adherence to Adjuvant Endocrine Therapy in Women With Breast Cancer: A Prospective Observational Study in Japanese Women.
    Clin Breast Cancer. 2017 Dec 12. pii: S1526-8209(17)30626.
    PubMed     Text format     Abstract available


  116. SHEPPARD VB, de Mendoza AH, He J, Jennings Y, et al
    Initiation of Adjuvant Endocrine Therapy in Black and White Women With Breast Cancer.
    Clin Breast Cancer. 2017 Dec 12. pii: S1526-8209(17)30356.
    PubMed     Text format     Abstract available


  117. CHIBA A, Raman R, Thomas A, Lamy PJ, et al
    Serum Vitamin D Levels Affect Pathologic Complete Response in Patients Undergoing Neoadjuvant Systemic Therapy for Operable Breast Cancer.
    Clin Breast Cancer. 2017 Dec 11. pii: S1526-8209(17)30324.
    PubMed     Text format     Abstract available


  118. ELGHOROURY EA, ElDine HG, Kamel SA, Abdelrahman AH, et al
    Evaluation of miRNA-21 and miRNA Let-7 as Prognostic Markers in Patients With Breast Cancer.
    Clin Breast Cancer. 2017 Dec 7. pii: S1526-8209(17)30458.
    PubMed     Text format     Abstract available


  119. SCIMECA M, Antonacci C, Toschi N, Giannini E, et al
    Breast Osteoblast-like Cells: A Reliable Early Marker for Bone Metastases From Breast Cancer.
    Clin Breast Cancer. 2017 Dec 5. pii: S1526-8209(17)30209.
    PubMed     Text format     Abstract available


    November 2017
  120. BASTIAANNET E, Charman J, Johannesen TB, Schrodi S, et al
    A European, Observational Study of Endocrine Therapy Administration in Patients With an Initial Diagnosis of Hormone Receptor-Positive Advanced Breast Cancer.
    Clin Breast Cancer. 2017 Nov 29. pii: S1526-8209(17)30728.
    PubMed     Text format     Abstract available


  121. LANDMAN Y, Ilouze M, Wein S, Neiman V, et al
    Rapid Response to Larotrectinib (LOXO-101) in an Adult Chemotherapy-Naive Patients With Advanced Triple-Negative Secretory Breast Cancer Expressing ETV6-NTRK3 Fusion.
    Clin Breast Cancer. 2017 Nov 28. pii: S1526-8209(17)30561.
    PubMed     Text format    


  122. HAMELINCK VC, Bastiaannet E, Pieterse AH, van de Velde CJH, et al
    Preferred and Perceived Participation of Younger and Older Patients in Decision Making About Treatment for Early Breast Cancer: A Prospective Study.
    Clin Breast Cancer. 2017 Nov 28. pii: S1526-8209(17)30409.
    PubMed     Text format     Abstract available


  123. RASOOL I, Afroze D, Wani KA, Yousuf A, et al
    Role of the Functional Polymorphism of Survivin Gene (-31G/C) and Risk of Breast Cancer in a North Indian Population.
    Clin Breast Cancer. 2017 Nov 23. pii: S1526-8209(17)30631.
    PubMed     Text format     Abstract available


  124. FURRER D, Jacob S, Michaud A, Provencher L, et al
    Association of Tobacco Use, Alcohol Consumption and HER2 Polymorphisms With Response to Trastuzumab in HER2-Positive Breast Cancer Patients.
    Clin Breast Cancer. 2017 Nov 23. pii: S1526-8209(17)30318.
    PubMed     Text format     Abstract available


  125. FLEMING CA, McCarthy K, Ryan C, McCarthy A, et al
    Evaluation of Discordance in Primary Tumor and Lymph Node Response After Neoadjuvant Therapy in Breast Cancer.
    Clin Breast Cancer. 2017 Nov 23. pii: S1526-8209(17)30679.
    PubMed     Text format     Abstract available


  126. CHANG HT, Pan HJ, Lee CH
    Prevention of Tamoxifen-related Nonalcoholic Fatty Liver Disease in Breast Cancer Patients.
    Clin Breast Cancer. 2017 Nov 23. pii: S1526-8209(17)30357.
    PubMed     Text format     Abstract available


  127. KIM JY, Jung EJ, Park HJ, Lee JH, et al
    Tumor-Suppressing Effect of Silencing of Annexin A3 Expression in Breast Cancer.
    Clin Breast Cancer. 2017 Nov 21. pii: S1526-8209(17)30504.
    PubMed     Text format     Abstract available


  128. INOUE Y, Yamashita N, Kitao H, Tanaka K, et al
    Clinical Significance of the Wild Type p53-Induced Phosphatase 1 Expression in Invasive Breast Cancer.
    Clin Breast Cancer. 2017 Nov 21. pii: S1526-8209(17)30385.
    PubMed     Text format     Abstract available


  129. GRANDI G, Toss A, Cagnacci A, Marcheselli L, et al
    Combined Hormonal Contraceptive Use and Risk of Breast Cancer in a Population of Women With a Family History.
    Clin Breast Cancer. 2017 Nov 14. pii: S1526-8209(17)30488.
    PubMed     Text format     Abstract available


  130. CHKHEIDZE R, Sanders MAG, Haley B, Leitch AM, et al
    Isolated Contralateral Axillary Lymph Node Involvement in Breast Cancer Represents a Locally Advanced Disease Not Distant Metastases.
    Clin Breast Cancer. 2017 Nov 10. pii: S1526-8209(17)30456.
    PubMed     Text format     Abstract available


  131. KARAKAS Y, Dizdar O, Aksoy S, Hayran M, et al
    The Effect of Total Size of Lesions in Multifocal/Multicentric Breast Cancer on Survival.
    Clin Breast Cancer. 2017 Nov 9. pii: S1526-8209(17)30449.
    PubMed     Text format     Abstract available


  132. HOU Y, Nitta H, Wei L, Banks PM, et al
    Evaluation of Immune Reaction and PD-L1 Expression Using Multiplex Immunohistochemistry in HER2-Positive Breast Cancer: The Association With Response to Anti-HER2 Neoadjuvant Therapy.
    Clin Breast Cancer. 2017 Nov 9. pii: S1526-8209(17)30604.
    PubMed     Text format     Abstract available


  133. RAGHAVENDRA A, Sinha AK, Valle J, Shen Y, et al
    Determinants of Weight Gain During Adjuvant Endocrine Therapy and Association of Such Weight Gain With Recurrence in Long-term Breast Cancer Survivors.
    Clin Breast Cancer. 2017 Nov 9. pii: S1526-8209(17)30621.
    PubMed     Text format     Abstract available


  134. FIGUEIREDO FWDS, Adami F
    Income Inequality and Mortality Owing to Breast Cancer: Evidence From Brazil.
    Clin Breast Cancer. 2017 Nov 9. pii: S1526-8209(17)30526.
    PubMed     Text format     Abstract available


  135. WADASADAWALA T, Lewis S, Parmar V, Budrukkar A, et al
    Bilateral Breast Cancer After Multimodality Treatment: A Report of Clinical Outcomes in an Asian Population.
    Clin Breast Cancer. 2017 Nov 9. pii: S1526-8209(17)30383.
    PubMed     Text format     Abstract available


  136. FISCHER A, Ziogas A, Anton-Culver H
    Negative Valence Life Events Promote Breast Cancer Development.
    Clin Breast Cancer. 2017 Nov 1. pii: S1526-8209(16)30501.
    PubMed     Text format     Abstract available


    October 2017
  137. MCREE AJ, Marcom PK, Moore DT, Zamboni WC, et al
    A Phase I Trial of the PI3K Inhibitor Buparlisib Combined With Capecitabine in Patients With Metastatic Breast Cancer.
    Clin Breast Cancer. 2017 Oct 28. pii: S1526-8209(17)30313.
    PubMed     Text format     Abstract available


  138. MCVEIGH TP, Wiggins J, Ward S, Kemp Z, et al
    Successful Repatriation of Breast Cancer Surveillance for High-Risk Women to the UK National Health Service Breast Screening Programme.
    Clin Breast Cancer. 2017 Oct 28. pii: S1526-8209(17)30489.
    PubMed     Text format     Abstract available


  139. PROCHOWSKI IAMURRI A, Ponziani M, Macchini M, Fogante M, et al
    Evaluation of Multifocality and Multicentricity With Breast Magnetic Resonance Imaging in Each Breast Cancer Subtype.
    Clin Breast Cancer. 2017 Oct 28. pii: S1526-8209(17)30164.
    PubMed     Text format     Abstract available


  140. SALOUSTROS E, Nikolaou M, Kalbakis K, Polyzos A, et al
    Weekly Paclitaxel and Carboplatin Plus Bevacizumab as First-Line Treatment of Metastatic Triple-Negative Breast Cancer. A Multicenter Phase II Trial by the Hellenic Oncology Research Group.
    Clin Breast Cancer. 2017 Oct 24. pii: S1526-8209(17)30153.
    PubMed     Text format     Abstract available


  141. HARDEFELDT PJ, Penninkilampi R, Edirimanne S, Eslick GD, et al
    Physical Activity and Weight Loss Reduce the Risk of Breast Cancer: A Meta-analysis of 139 Prospective and Retrospective Studies.
    Clin Breast Cancer. 2017 Oct 17. pii: S1526-8209(16)30429.
    PubMed     Text format     Abstract available


  142. KUROSKY SK, Mitra D, Zanotti G, Kaye JA, et al
    Treatment Patterns and Outcomes of Patients With Metastatic ER(+)/HER-2(-) Breast Cancer: A Multicountry Retrospective Medical Record Review.
    Clin Breast Cancer. 2017 Oct 14. pii: S1526-8209(17)30060.
    PubMed     Text format     Abstract available


  143. CHANG AE, Wu QV, Jenkins IC, Specht JM, et al
    Phase I/II Trial of Combined Pegylated Liposomal Doxorubicin and Cyclophosphamide in Metastatic Breast Cancer.
    Clin Breast Cancer. 2017 Oct 9. pii: S1526-8209(17)30280.
    PubMed     Text format     Abstract available


  144. JANDIAL R, Hoshide R, Waters JD, Somlo G, et al
    Operative and Therapeutic Advancements in Breast Cancer Metastases to the Brain.
    Clin Breast Cancer. 2017 Oct 7. pii: S1526-8209(17)30417.
    PubMed     Text format     Abstract available


  145. HIEKEN TJ, Murphy BL, Boughey JC, Degnim AC, et al
    Influence of Biologic Subtype of Inflammatory Breast Cancer on Response to Neoadjuvant Therapy and Cancer Outcomes.
    Clin Breast Cancer. 2017 Oct 7. pii: S1526-8209(17)30370.
    PubMed     Text format     Abstract available


  146. RAISS H, Peron J, Tartas S, Trillet-Lenoir V, et al
    Palbociclib-Induced Thrombotic Microangiopathy in Metastatic Breast Cancer Patient Surviving for 18 Years: Case Report and Review of the Literature.
    Clin Breast Cancer. 2017 Oct 7. pii: S1526-8209(17)30072.
    PubMed     Text format    


  147. HAYASHI N, Takahashi Y, Matsuda N, Tsunoda H, et al
    The Prognostic Effect of Changes in Tumor Stage and Nodal Status After Neoadjuvant Chemotherapy in Each Primary Breast Cancer Subtype.
    Clin Breast Cancer. 2017 Oct 3. pii: S1526-8209(17)30319.
    PubMed     Text format     Abstract available


    September 2017
  148. HOUSSAMI N
    Evidence on Synthesized Two-dimensional Mammography Versus Digital Mammography When Using Tomosynthesis (Three-dimensional Mammography) for Population Breast Cancer Screening.
    Clin Breast Cancer. 2017 Sep 28. pii: S1526-8209(17)30558.
    PubMed     Text format     Abstract available


  149. HEGDE JV, Wang X, Attai DJ, DiNome ML, et al
    Assessing the Effect of Lifetime Contralateral Breast Cancer Risk on the Selection of Contralateral Prophylactic Mastectomy for Unilateral Breast Cancer.
    Clin Breast Cancer. 2017 Sep 27. pii: S1526-8209(17)30512.
    PubMed     Text format     Abstract available


  150. ITO T, Oura S, Nagamine S, Takahashi M, et al
    Radiofrequency Ablation of Breast Cancer: A Retrospective Study.
    Clin Breast Cancer. 2017 Sep 25. pii: S1526-8209(17)30241.
    PubMed     Text format     Abstract available


  151. LEAL AD, Van Houten H, Sangaralingham L, Freedman RA, et al
    Breast Cancer Survivorship Care Variations Between Adjuvant Chemotherapy Regimens.
    Clin Breast Cancer. 2017 Sep 22. pii: S1526-8209(17)30422.
    PubMed     Text format     Abstract available


  152. AKIMOTO E, Kadoya T, Kajitani K, Emi A, et al
    Role of 18F-PET/CT in Predicting Prognosis of Patients With Breast Cancer After Neoadjuvant Chemotherapy.
    Clin Breast Cancer. 2017 Sep 19. pii: S1526-8209(17)30037.
    PubMed     Text format     Abstract available


  153. WU J, Wang S, Liu F, Li S, et al
    Single Nucleotide Polymorphisms in the Acylphosphatase 2 Gene and The SNP-SNP Interactions on the Risk of Breast Cancer in Chinese Han Women.
    Clin Breast Cancer. 2017 Sep 19. pii: S1526-8209(17)30157.
    PubMed     Text format     Abstract available


  154. DIANATINASAB M, Mohammadianpanah M, Daneshi N, Zare-Bandamiri M, et al
    Socioeconomic Factors, Health Behavior, and Late-Stage Diagnosis of Breast Cancer: Considering the Impact of Delay in Diagnosis.
    Clin Breast Cancer. 2017 Sep 19. pii: S1526-8209(17)30358.
    PubMed     Text format     Abstract available


  155. MANN JM, Wu X, Christos P, Nagar H, et al
    The State of Surgical Axillary Management and Adjuvant Radiotherapy for Early-stage Invasive Breast Cancer in the Modern Era.
    Clin Breast Cancer. 2017 Sep 19. pii: S1526-8209(17)30461.
    PubMed     Text format     Abstract available


  156. SAFRA T, Kaufman B, Kadouri L, Efrat Ben-Baruch N, et al
    Everolimus Plus Letrozole for Treatment of Patients With HR+, HER2- Advanced Breast Cancer Progressing on Endocrine Therapy: An Open-label, Phase II Trial.
    Clin Breast Cancer. 2017 Sep 19. pii: S1526-8209(17)30180.
    PubMed     Text format     Abstract available


  157. SPINELLI VARELLA MA, Teixeira da Cruz J, Rauber A, Varella IS, et al
    Role of BI-RADS Ultrasound Subcategories 4A to 4C in Predicting Breast Cancer.
    Clin Breast Cancer. 2017 Sep 19. pii: S1526-8209(16)30505.
    PubMed     Text format     Abstract available


  158. OBERGUGGENBERGER A, Meraner V, Sztankay M, Hilbert A, et al
    Health Behavior and Quality of Life Outcome in Breast Cancer Survivors: Prevalence Rates and Predictors.
    Clin Breast Cancer. 2017 Sep 18. pii: S1526-8209(17)30454.
    PubMed     Text format     Abstract available


  159. FERNANDEZ-GONZALEZ S, Falo C, Pla MJ, Pernas S, et al
    The Shift From Sentinel Lymph Node Biopsy Performed Either Before or After Neoadjuvant Systemic Therapy in the Clinical Negative Nodes of Breast Cancer Patients. Results, and the Advantages and Disadvantages of Both Procedures.
    Clin Breast Cancer. 2017 Sep 4. pii: S1526-8209(17)30565.
    PubMed     Text format     Abstract available


  160. ANAMPA J, Chen A, Wright J, Patel M, et al
    Phase I Trial of Veliparib, a Poly ADP Ribose Polymerase Inhibitor, Plus Metronomic Cyclophosphamide in Metastatic HER2-negative Breast Cancer.
    Clin Breast Cancer. 2017 Sep 1. pii: S1526-8209(17)30468.
    PubMed     Text format     Abstract available


  161. ROGOZ B, Houze de l'Aulnoit A, Duhamel A, Houze de l'Aulnoit D, et al
    Thirty-Year Trends of Survival and Time-Varying Effects of Prognostic Factors in Patients With Metastatic Breast Cancer-A Single Institution Experience.
    Clin Breast Cancer. 2017 Sep 1. pii: S1526-8209(16)30427.
    PubMed     Text format     Abstract available


    August 2017
  162. CHAMP CE, Ohri N, Klement RJ, Cantor M, et al
    Assessing Changes in the Activity Levels of Breast Cancer Patients During Radiation Therapy.
    Clin Breast Cancer. 2017 Aug 24. pii: S1526-8209(17)30285.
    PubMed     Text format     Abstract available


  163. CHAO YL, Anders CK
    TYMS Gene Polymorphisms in Breast Cancer Patients Receiving 5-Fluorouracil-Based Chemotherapy.
    Clin Breast Cancer. 2017 Aug 19. pii: S1526-8209(17)30369.
    PubMed     Text format    


  164. WANG Y, Brodsky AS, Xiong J, Lopresti ML, et al
    Stromal Clusterin Expression Predicts Therapeutic Response to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer.
    Clin Breast Cancer. 2017 Aug 19. pii: S1526-8209(17)30349.
    PubMed     Text format     Abstract available


  165. CID S, Eiro N, Fernandez B, Sanchez R, et al
    Prognostic Influence of Tumor Stroma on Breast Cancer Subtypes.
    Clin Breast Cancer. 2017 Aug 19. pii: S1526-8209(17)30189.
    PubMed     Text format     Abstract available


  166. CHOI WJ, Kim WK, Shin HJ, Cha JH, et al
    Evaluation of the Tumor Response After Neoadjuvant Chemotherapy in Breast Cancer Patients: Correlation Between Dynamic Contrast-enhanced Magnetic Resonance Imaging and Pathologic Tumor Cellularity.
    Clin Breast Cancer. 2017 Aug 18. pii: S1526-8209(17)30058.
    PubMed     Text format     Abstract available


  167. AZIM HA, Abdel-Malek R, Kassem L
    Predicting Brain Metastasis in Breast Cancer Patients: Stage Versus Biology.
    Clin Breast Cancer. 2017 Aug 18. pii: S1526-8209(17)30235.
    PubMed     Text format     Abstract available


  168. KOOL M, Bastiaannet E, Van de Velde CJH, Marang-van de Mheen PJ, et al
    Reliability of Self-reported Treatment Data by Patients With Breast Cancer Compared With Medical Record Data.
    Clin Breast Cancer. 2017 Aug 18. pii: S1526-8209(17)30212.
    PubMed     Text format     Abstract available


  169. DONG H, Huang Y, Song F, Dai H, et al
    Improved Performance of Adjunctive Ultrasonography After Mammography Screening for Breast Cancer Among Chinese Females.
    Clin Breast Cancer. 2017 Aug 15. pii: S1526-8209(17)30321.
    PubMed     Text format     Abstract available


  170. CHEN W, Huang Y, Lewis GD, Szeja SS, et al
    Treatment Outcomes and Prognostic Factors in Male Patients With Stage IV Breast Cancer: A Population-based Study.
    Clin Breast Cancer. 2017 Aug 10. pii: S1526-8209(17)30185.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: